XML 38 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
Financial Instruments and Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2015
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The financial instruments measured at fair value on a recurring basis at March 31, 2015 were as follows:
 
Level 1
 
Level 2
 
Level 3
 
Total Fair Value
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
23,406

 
$

 
$

 
$
23,406

Commercial paper
248,354

 

 

 
248,354

Debt securities:
 
 
 
 
 
 
 
U.S. Treasury securities
259,929

 

 

 
259,929

Corporate debt securities

 
101,193

 

 
101,193

Preferred stock

 
24,258

 

 
24,258

Restricted investments:
 
 
 
 
 
 
 
Guaranteed income fund

 
7,099

 

 
7,099

 
$
531,689

 
$
132,550

 
$

 
$
664,239



The financial instruments measured at fair value on a recurring basis at December 31, 2014 were as follows:
 
Level 1
 
Level 2
 
Level 3
 
Total Fair Value
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
19,971

 
$

 
$

 
$
19,971

Debt securities:
 
 
 
 
 
 
 
U.S. Treasury securities
509,815

 

 

 
509,815

Corporate debt securities

 
100,105

 

 
100,105

Preferred stock

 
26,958

 

 
26,958

Restricted investments:
 
 
 
 
 
 


Guaranteed income fund

 
7,940

 

 
7,940

 
$
529,786

 
$
135,003

 
$

 
$
664,789

Carrying Amount and Fair Value of Financial Instruments
The carrying amount and fair value of the Company’s financial instruments were as follows:
 
March 31, 2015
 
December 31, 2014
 
Carrying 
value
 
Fair value
 
Level
 
Carrying 
value
 
Fair value
 
Level
Assets
 
 
 
 
 
 
 
 
 
 
 
Pledged treasury securities
$
25,512

 
$
26,002

 
1
 
$
25,670

 
$
26,501

 
1
Retained interest investments
$
9,974

 
$
13,055

 
3
 
$
9,932

 
$
13,026

 
3
Investments held by special purpose entities (Note 5)
$
209,412

 
209,473

 
3
 
$
209,857

 
$
209,679

 
3
Liabilities
 
 
 
 
 
 
 
 
 
 
 
Senior Notes held by special purpose entity (Note 5)
$
177,366

 
177,966

 
3
 
$
177,341

 
$
177,940

 
3